Li YX. Clinical curative effect observation of Shufeng Jiedu capsule on wind-heat cold. Clin J Tradit Chin Med. 2015;27(05):674–5.
Hu R, Wang LH, Zhang JJ, et al. Clinical observation of Shufeng Jiedu Capsule for treating acute pharyngitis. Drug Eval Res. 2014;37(05):460–2.
Ren H, Jiang Y, Wang S, et al. Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a protocol for systematic review and meta-analysis. Medicine. 2021;100(1): e24198.
Article CAS PubMed PubMed Central Google Scholar
Hu XY, Oliver T, Willcox M, et al. Treating acute exacerbations of COPD with Chinese herbal medicine to aid antibiotic use reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial. Pilot Feasibility Stud. 2022;8(1):262.
Article PubMed PubMed Central Google Scholar
Zhang XW, Xia RY, Gao JQ, et al. Chinese patent medicine Shufeng Jiedu Capsules as an adjuvant therapy for community-acquired pneumonia: a systematic review and meta-Analysis of randomized clinical trials. Front Pharmacol. 2022;13: 923395.
Article CAS PubMed PubMed Central Google Scholar
Ji S, Bai Q, Wu X, et al. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease. Biomed Pharmacother. 2020;121: 109652.
Article CAS PubMed Google Scholar
Chen J, Lin S, Niu C, et al. Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study. Expert Rev Respir Med. 2021;15(2):257–65.
Article CAS PubMed Google Scholar
Zhang B, Pei W, Cai P, et al. Recent advances in Chinese patent medicines entering the international market. Drug Discov Ther. 2022;16(6):258–72.
Guo MN, Liu SX, Zhao YM, et al. Analysis on chemical constituents in Bupleuri Radix by HPLC-Q-TOF-MS. Chin Tradit Herbal Drugs. 2016;47(12):2044–52.
Zhang CX, Liu SX, Zhao YM, et al. Analysis on chemical constituents from Forsythiae Fructus by HPLC-Q-TOF-MS. Chin Tradit Herbal Drugs. 2016;47(12):2053–60.
Zhao YM, Liu SX, Zhang CX, et al. Analysis on chemical constituents from Glycyrrhizae Radix et Rhizoma by HPLC-Q-TOF-M. Chin Tradit Herbal Drugs. 2016;47(12):2027–33.
Zhang TJ, Zhu YX, Liu SX, et al. Promotion on systematic quality standard of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2016;47(12):2061–8.
Zhang TJ, Zhu YX, Liu DL, et al. Study on pharmacodynamic material basis and mechanism of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2016;47(12):2019–26.
Zhang TJ, Zhu YX, Liu DL, et al. Systematic research of secondary development of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2019;50(15):3517–25.
Li Y, Chang N, Han Y, et al. Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory infection via the ERK pathway. Biomed Pharmacother. 2017;94:758–66.
Liu X, Zhang H, Xu J, et al. Identification of absorbed components and their metabolites in rat plasma after oral administration of Shufeng Jiedu capsule using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 2019;33(19):1494–501.
Article CAS PubMed Google Scholar
Tao Z, Meng X, Han YQ, et al. Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an acute lung injury animal model using quantitative proteomics technology. J Proteome Res. 2017;16(11):4009–19.
Article CAS PubMed Google Scholar
Tao Z, Chen J, Su J, et al. Quantitative Proteomics analysis of systemic responses and biological mechanisms of ShuFengJieDu Capsule Using H1N1-Infected RAW264.7 Cells. ACS Omega. 2020;5(25):15417–23.
Article CAS PubMed PubMed Central Google Scholar
Han YQ, Cao Y, Dong YN, et al. Spectrum-effect relationship of anti-inflammatory activity of Shufeng Jiedu Capsule based on neural network analysis. Chin Tradit Herbal Drugs. 2019;50(15):3526–33.
Han YQ, Cao Y, Dong YN, et al. Spectrum-effect relationship of wind-dispersing and exterior syndrome-relieving of Shufeng Jiedu Capsules. Chinese Tradit Herbal Drugs. 2019;50(15):3534–40.
Bao Y, Gao Y, Cui X. Efect of Shufeng Jiedu capsules as a broad-spectrum antibacterial. Biosci Trends. 2016;10:74–8.
Article CAS PubMed Google Scholar
Lv WW, Zhu TN, Qiu H, et al. Pharmacodynamic study on antiviral and antibacterial effects of Shufeng Jiedu capsules in vitro. Tradit Chin Drug Res Clin Pharmacol. 2013;24(3):234–8.
Bao YY, Gao YJ, Shi YJ, et al. Study on Broad-spectrum antiviral effect of Shufeng Jiedu Capsules. J New Chin Med. 2019;51(12):5–8.
Liu Y, Cui XL, Shi H, et al. Study on pharmacodynamic trial in Vivo of Shufengjiedu capsule on prevention and treatment of influenza. World J Integr Tradit Western Med. 2010;5(01):35–9.
Liu Y, Shi H, Jin YH, et al. Experimental pharmacodynamic research in Vivo of Shufengjiedu capsule on treatment and prevention of influenza. World J Integ Tradit Western Med. 2010;5(02):107–10.
Li ZH, Zhang H, Chen JL, et al. Shufeng-Jiedu capsule protects against pneumonia induced by influenza A virus H1N1 via miR-155/JAK1-STAT1 signaling pathway in mice. Chin J Pathophysiol. 2022;38(7):1219–25.
Qiu H, Li ZC, Zhu TN, et al. In-vivo experimental research of antiviral action of Shufeng Jiedu Capsule. Tradit Chin Drug Res Clin Pharmacol. 2014;25(1):14–7.
Xia L, Shi Y, Su J, et al. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine. 2021;85: 153390.
Article CAS PubMed Google Scholar
Simayi J, Nuermaimaiti M, Wumaier A, et al. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking. Medicine. 2022;101(1): e28286.
Article CAS PubMed PubMed Central Google Scholar
Xiong H, Dong Z, Lou G, et al. Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools. Eur J Integr Med. 2020;40: 101241.
Article PubMed PubMed Central Google Scholar
Chen X, Yin YH, Zhang MY, et al. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology. Int J Med Sci. 2020;17(16):2511–30.
Article CAS PubMed PubMed Central Google Scholar
Zhuang Z, Zhong X, Zhang H, et al. Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by comprehensive network pharmacological approaches and molecular docking validation. Comb Chem High Throughput Screen. 2021;24(9):1377–94.
Article CAS PubMed Google Scholar
Tao Z, Zhang L, Friedemann T, et al. Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia. J Funct Foods. 2020;75: 104243.
Article CAS PubMed PubMed Central Google Scholar
Tao Z, Gao J, Zhang G, et al. Shufeng Jiedu Capsule protect against acute lung injury by suppressing the MAPK/NF-κB pathway. Biosci Trends. 2014;8(1):45–51.
Tao ZG, Gao JY, Xue MM, et al. Shufeng Jiedu Capsule regulates LPS-induced acute lung injury via inhibiting MAPK/NF-κB pathways. China J Tradit Chin Med Pharm. 2014;29(3):911–5.
Yuan Y, Liao Q, Xue M, et al. Shufeng Jiedu Capsules alleviate lipopolysaccharide-induced acute lung inflammatory injury via activation of GPR18 by verbenalin. Cell Physiol Biochem. 2018;50(2):629–39.
Article CAS PubMed Google Scholar
Cai J, Wang YL, Sheng XD, et al. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI. J Ethnopharmacol. 2022;298: 115661.
Article CAS PubMed PubMed Central Google Scholar
Liao Q, Chen W, Tong Z, et al. Shufeng Jiedu capsules protect rats against LPS-induced acute lung injury via activating NRF2-associated antioxidant pathway. Histol Histopathol. 2021;36(3):317–24.
Mei J, Kong H, Zhao Z, et al. Shufengjiedu capsules protect against neuronal loss in olfactory epithelium and lung injury by enhancing autophagy in rats with allergic rhinitis. Biosci Trends. 2020;13(6):530–8.
He ZL, Fang WJ, Zhang FB, et al. Effect of intestinal absorption liquid containing breeze detoxification capsule on lps-induced cytokines reaction in macrophage. Modern Chin Med. 2015;17(4):345–8.
Ma L, Huang Y, Hou YB, et al. Anti-inflammatory mechanism of Shufeng Jiedu Capsules in rat pneumonia model. Chin Tradit Herbal Drugs. 2018;49(19):4591–5.
Shi J, Luo Y. Effect of Shufeng Jiedu capsule on the repair mechanism and immunologic function of COPD mouse pulmonary oxidative damage. Prog Anatomical Sci. 2021;27(5):561–4.
Wu FH, Song RJ, Cai CY, et al. Effect of Shufeng Jiedu Capsules on serum T cell subsets CD3+, CD4+ /CD8+ in rats with acute pharyngitis. Beijing J Tradit Chin Med. 2020;39(7):689–92.
Han YQ, Dong YN, Xu J, et al. Study on mechanism of anti-inflammation and immunoregulation of Shufeng Jiedu Capsule based on network pharmacology. Chin Tradit Herbal Drugs. 2019;50(15):3555–62.
Wang ZY, Ge L, Meng ZJ, et al. Pharmacodynamics and pharmacoeconomic analysis of the antipyretic effects of Chaiqinqingning capsule, Qingkailing capsule, Qingrejiedu capsule, Shufengjiedu capsule. Chin J Clin Rat Drug Use. 2019;12(11A):3–6.
Liu J, Ma L, Lu J, et al. Study on mechanism for antipyretic effects of Shufeng Jiedu Capsule. Chin Tradit Herbal Drugs. 2016;47(12):2040–3.
留言 (0)